RESUMEN
Preeclampsia is a pregnancy-specific syndrome that has been the greatest cause of maternal and fetal morbidity and mortality. The impaired outcomes are related to maternal and the offspring healthy in the short and long-term. Although preeclampsia origins remain unclear, it is well known that there is impaired trophoblast invasion with culminant abnormal immune response. The early and late-onset preeclampsia have been studied, the subtypes have the same difference in the placentation and inflammatory features. Dietary compounds can stimulate or inhibit the activation of immune cells. Low vitamin D intake has been linked to impaired fetal development, intrauterine growth restriction, and preeclampsia. Vitamin D has been described as an anti-inflammatory effect. It can downregulate pro-inflammatory cytokines expression by the inhibition of the Nuclear Factor-ĸB pathway signaling cascade. High vitamin D levels could attenuate the immune response. On the other hand, vitamin D deficiency may contribute to increasing pro-inflammatory state. In preeclampsia, there is a reduced expression of vitamin D receptor and its metabolism is disrupted. In this review, we aimed to discuss the role of vitamin D as an anti-inflammatory agent in relation to the pro-inflammatory process of preeclampsia through the activation of the TLR4 pathway. Although there are limited studies showing the relation between vitamin D and lower risk of preeclampsia, the maternal status of vitamin D seems to influence the risk of PE development. Therefore, vitamin D supplementation in women may be a strategy to improve pregnancy outcomes.
Asunto(s)
Preeclampsia/inmunología , Receptores de Calcitriol/inmunología , Receptor Toll-Like 4/inmunología , Vitamina D/inmunología , Animales , Femenino , Humanos , Inflamación/complicaciones , Inflamación/inmunología , Inflamación/patología , Preeclampsia/etiología , Preeclampsia/patología , Embarazo , Transducción de Señal , Deficiencia de Vitamina D/complicaciones , Deficiencia de Vitamina D/inmunología , Deficiencia de Vitamina D/patologíaRESUMEN
Maternal immune dysregulation seems to affect fetal or postnatal immune development. Preeclampsia is a pregnancy-associated disorder with an immune basis and is linked to atopic disorders in offspring. Here we show reduction of fetal thymic size, altered thymic architecture and reduced fetal thymic regulatory T (Treg) cell output in preeclamptic pregnancies, which persists up to 4 years of age in human offspring. In germ-free mice, fetal thymic CD4+ T cell and Treg cell development are compromised, but rescued by maternal supplementation with the intestinal bacterial metabolite short chain fatty acid (SCFA) acetate, which induces upregulation of the autoimmune regulator (AIRE), known to contribute to Treg cell generation. In our human cohorts, low maternal serum acetate is associated with subsequent preeclampsia, and correlates with serum acetate in the fetus. These findings suggest a potential role of acetate in the pathogenesis of preeclampsia and immune development in offspring.
Asunto(s)
Acetatos/sangre , Feto/inmunología , Preeclampsia/inmunología , Efectos Tardíos de la Exposición Prenatal/inmunología , Linfocitos T Reguladores/inmunología , Acetatos/administración & dosificación , Acetatos/inmunología , Acetatos/metabolismo , Adulto , Animales , Animales Recién Nacidos , Estudios de Casos y Controles , Desarrollo Infantil , Preescolar , Suplementos Dietéticos , Femenino , Feto/citología , Feto/diagnóstico por imagen , Microbioma Gastrointestinal/inmunología , Vida Libre de Gérmenes/inmunología , Humanos , Tolerancia Inmunológica/inmunología , Lactante , Recién Nacido , Estudios Longitudinales , Intercambio Materno-Fetal/inmunología , Ratones , Tamaño de los Órganos/inmunología , Preeclampsia/sangre , Preeclampsia/diagnóstico , Embarazo , Efectos Tardíos de la Exposición Prenatal/patología , Efectos Tardíos de la Exposición Prenatal/prevención & control , Estudios Prospectivos , Timo/citología , Timo/diagnóstico por imagen , Timo/crecimiento & desarrollo , Timo/inmunología , Factores de Transcripción/inmunología , Factores de Transcripción/metabolismo , Ultrasonografía Prenatal , Adulto Joven , Proteína AIRERESUMEN
INTRODUCTION: Preeclampsia (PE) is a systemic inflammatory disease, and its effect on human milk immune components is poorly understood. OBJECTIVE: To investigate whether PE affects human milk cytokine levels. METHODS: This was a prospective observational study involving mothers diagnosed with PE and with singleton pregnancy with no fetal malformation. The following cases were excluded: diabetes, chorioamnionitis, use of illicit drugs and alcohol, mastitis and congenital infection. In total, 228 mothers were studied and divided into two groups matched by gestational age: PE (n = 114) and normotensive (control, n = 114). Colostrum was collected from 24-72 hours postpartum, and mature milk was collected at the end of the first month. Cytokines (IL-1ß, IL-6, IL-8, IL-10, IL-12, and TNF-α) were measured using flow cytometry. A generalized linear model with a gamma distribution was used to analyze the differences between groups versus time interaction. RESULTS: The mean gestational age was 36 weeks. Increased IL-1 and IL-6 levels and reduced IL-12 levels in the colostrum were detected in PE, while in the mature milk, the IL-6 and IL-8 levels were lower than those of the control group. CONCLUSIONS: PE is associated with increased levels of inflammatory cytokines in colostrum and decreased levels in mature milk.
Asunto(s)
Calostro/inmunología , Leche Humana/inmunología , Preeclampsia/inmunología , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Recién Nacido , Interleucina-6/análisis , Interleucina-8/análisis , Embarazo , Estudios Prospectivos , Factor de Necrosis Tumoral alfa/análisis , Adulto JovenRESUMEN
OBJECTIVES: Preeclampsia is characterised by systemic endothelial cell dysfunction thought to be triggered by toxic/dangerous factors from the placenta, including placental extracellular vesicles (EVs). Why placental EVs become toxic is unknown. We previously reported that preeclamptic sera produced toxic/dangerous placental macrovesicles but whether small EVs are also toxic/dangerous in preeclampsia is unknown. STUDY DESIGN: First trimester placental explants were treated with 10% preeclamptic or control sera (n=10) for 24h. Micro- and nano-vesicles were harvested by sequential centrifugation. Micro- or nano-vesicles were also exposed to monolayers of endothelial cells in the presence or absence of nifedipine (50µg/ml) or labetalol (0.5µg/ml) which are well-known anti-hypertensives in clinical practices. MAIN OUTCOMES MEASURES: The number and size of micro- and nano-vesicles were counted. Endothelial cell-surface intercellular adhesion molecule 1 (ICAM-1) and high mobility group box 1 (HMGB1) levels in micro- or nano-vesicles were measured by immunoassays. RESULTS: Neither the amount nor size of both micro- and nano-vesicles was different after treating placental explants with preeclamptic or control sera. The levels of HMGB1 were significantly increased in both micro- and nano-vesicles from preeclamptic sera treated placental explants (p<0.03). Exposing endothelial cells to micro- or nano-vesicles from preeclamptic sera-treated placental explants induced endothelial activation, but it was reversed by co-incubation with nifedipine (p=0.004) or labetalol (p=0.002). CONCLUSION: Our data demonstrate that preeclamptic sera produce toxic/dangerous micro- and nano-placental EVs which activated endothelial cells. This effect was reversed by antihypertensives. The increased levels of HMGB1 in EVs may contribute to endothelial cell activation.
Asunto(s)
Células Endoteliales/inmunología , Proteína HMGB1/metabolismo , Sueros Inmunes/inmunología , Placenta/inmunología , Preeclampsia/inmunología , Células Cultivadas , Células Endoteliales/efectos de los fármacos , Vesículas Extracelulares/inmunología , Femenino , Humanos , Molécula 1 de Adhesión Intercelular/metabolismo , Labetalol/farmacología , Nanopartículas , Nifedipino/farmacología , Embarazo , Primer Trimestre del Embarazo , Tocolíticos/farmacología , Regulación hacia ArribaRESUMEN
BACKGROUND: The present study was designed to examine the effects of vitamin D plus calcium administration on metabolic profiles and pregnancy outcomes among women at risk for pre-eclampsia. METHODS: In a prospective, double-blind, placebo-controlled trial, 60 women at risk for pre-eclampsia were randomised to take either 50 000 IU vitamin D3 every 2 weeks plus 1000 mg day(-1) calcium supplements (as calcium carbonate) (n = 30) or to receive placebos at the same times (n = 30) from 20 to 32 weeks of gestation. Fasting blood samples were taken at baseline and 12 weeks after intervention to determine related variables. Newborn anthropometric measurements were determined. RESULTS: Taking combined cholecalciferol and calcium supplements, compared to placebo, led to significant reductions in fasting plasma glucose (FPG) [mean (SD)] [-5.7 (5.5) versus -0.6 (12.6) mg dL(-1) , P = 0.04], serum insulin concentrations [-2.8 (6.0) versus +7.7 (9.8) µIU mL(-1) , P < 0.001], homeostasis model of assessment-insulin resistance [-0.8 (1.3) versus +1.6 (2.2), P < 0.001], homeostatic model assessment-beta cell function [-8.2 (25.8) versus +32.6 (41.3, P < 0.001] and a significant rise in quantitative insulin sensitivity check index score [+0.02 (0.02) versus -0.02 (0.02, P < 0.001]. Additionally, pregnant women who received cholecalciferol plus calcium supplements had increased serum high-density lipoprotein (HDL)-cholesterol [+4.6 (8.3) versus -2.9 (7.7) mg dL(-1) , P = 0.001] and plasma total glutathione (GSH) concentrations [+23.4 (124.0) versus -94.8 (130.2) µm, P = 0.001] compared to placebo. However, after adjustment for the baseline levels, maternal age and baseline body mass index, the effects on FPG levels (P = 0.13) and systolic blood pressure (P = 0.13) disappeared. CONCLUSIONS: Vitamin D plus calcium administration for 12 weeks had beneficial effects on glycaemic status, HDL-cholesterol, GSH and blood pressure among women at risk for pre-eclampsia.
Asunto(s)
Calcio de la Dieta/uso terapéutico , Colecalciferol/uso terapéutico , Suplementos Dietéticos , Resistencia a la Insulina , Fenómenos Fisiologicos Nutricionales Maternos , Estrés Oxidativo , Preeclampsia/prevención & control , Adolescente , Adulto , Biomarcadores/sangre , Carbonato de Calcio/administración & dosificación , Método Doble Ciego , Femenino , Humanos , Mediadores de Inflamación/sangre , Irán/epidemiología , Preeclampsia/epidemiología , Preeclampsia/inmunología , Preeclampsia/metabolismo , Embarazo , Resultado del Embarazo , Nacimiento Prematuro/epidemiología , Nacimiento Prematuro/inmunología , Nacimiento Prematuro/metabolismo , Nacimiento Prematuro/prevención & control , Prevalencia , Riesgo , Adulto JovenRESUMEN
INTRODUCTION: A hallmark of preeclampsia is endothelial cell dysfunction/activation in response to "toxins" from the placenta. Necrotic trophoblastic debris (NTD) is one possible placental toxin and others include inflammatory cytokines. Calcium supplementation appears to protect "at-risk" women from developing preeclampsia by an unknown mechanism. In this study we investigate whether the addition of high levels of calcium to endothelial cells prior to their exposure to the preeclampsia-associated activators could reduce the endothelial cell activation. METHODS: NTD was harvested from 1st trimester placental explants. Endothelial cells were treated with varied concentrations of calcium prior to exposure to NTD, IL-6 or preeclamptic sera or low levels of calcium. Activation was monitored by quantifying endothelial cell-surface ICAM-1 by ELISA or U937 adhesion to endothelial cells. The activity of endothelial cell nitric oxide synthetase was blocked with L-NAME. RESULTS: Pre-treatment with increasing concentrations of calcium inhibited the activation of endothelial cells in response to NTD or IL-6 or preeclamptic sera. Inhibiting nitric oxide synthetase, using L-NAME, reduced the ability of high calcium levels to protect endothelial cell activation. Pre-treatment with calcium did not prevent endothelial cell activation induced by the reduction of the levels of calcium but additional calcium treatment did prevent endothelial cell activation induced by low calcium. CONCLUSION: Our results demonstrate calcium supplementation may prevent the activation of the endothelium in response to activators. These results may partially explain the benefits of calcium supplementation in the reduction of risk for developing preeclampsia and provide in vitro mechanistic support for the use of calcium supplementation in at-risk women.
Asunto(s)
Calcio/metabolismo , Comunicación Celular , Endotelio Vascular/metabolismo , Interleucina-6/metabolismo , Placenta/metabolismo , Preeclampsia/metabolismo , Calcio de la Dieta/uso terapéutico , Línea Celular , Sistema Libre de Células , Suplementos Dietéticos , Endotelio Vascular/inmunología , Femenino , Humanos , Interleucina-6/sangre , Interleucina-6/genética , Necrosis , Concentración Osmolar , Placenta/irrigación sanguínea , Placenta/inmunología , Placenta/patología , Circulación Placentaria , Preeclampsia/inmunología , Preeclampsia/patología , Preeclampsia/prevención & control , Embarazo , Primer Trimestre del Embarazo , Proteínas Recombinantes/metabolismo , Factores de Tiempo , Técnicas de Cultivo de TejidosRESUMEN
OBJECTIVES: Preeclampsia is a pregnancy specific disorder connected with endothelial cell dysfunction. In vitro stimulation of preeclamptic placental endothelial cell with Ureaplasma urealyticum will help in understanding its relationship with the host cell. Metals and metal-containing compounds are known to play important roles in many biological processes, including metabolic pathway, inflammation and function of proteins. STUDY DESIGN: The variation in expression of various metals was assessed for the first time using FESEM (Field Emission Scanning Electron Microscope) with EDX (Energy Dispersive X-ray spectroscopy) technique in endothelial cells isolated from normotensive and preeclamptic placenta with and without in vitro U. urealyticum stimulation. The results were correlated with the expression of HSP (heat shock protein) 70 in all the 4 endothelial cells. RESULTS: Preeclampsia and U. urealyticum infection alters endothelial cell size, HSP70 expression and metal (sodium, potassium, calcium, iron) concentration. There is a significant increase in the concentration of iron and calcium and decrease in HSP70 expression and endothelial cell size in preeclamptic endothelial cell with U. urealyticum stimulation. CONCLUSION: This work is the first step in the identification of metals pertinent to mollicute infection and lays the foundation for future studies concentrating on characterization of these metal associated or containing molecules. The ionic imbalance observed infers that calcium and iron supplementation should be executed with caution both during preeclampsia and U. urealyticum infection in pregnancy. This study also suggests that the HSP70 mediated protection exhibited in endothelial cell during preeclampsia is lost upon U. urealyticum infection which further contributes to the observed endothelial cell damage.
Asunto(s)
Calcio/metabolismo , Endotelio Vascular/metabolismo , Endotelio Vascular/microbiología , Hierro/metabolismo , Placenta/irrigación sanguínea , Preeclampsia/metabolismo , Ureaplasma urealyticum/inmunología , Adulto , Adhesión Bacteriana , Tamaño de la Célula , Supervivencia Celular , Células Cultivadas , Electrólitos/metabolismo , Endotelio Vascular/inmunología , Endotelio Vascular/ultraestructura , Femenino , Proteínas HSP70 de Choque Térmico/metabolismo , Humanos , Microscopía Electrónica de Rastreo , Preeclampsia/inmunología , Preeclampsia/microbiología , Preeclampsia/patología , Embarazo , Espectrometría por Rayos X , Infecciones por Ureaplasma/complicaciones , Adulto JovenRESUMEN
Vitamin D has been suggested to affect the balance between T helper (Th1) and (Th2) type cytokines by favouring Th2 domination. We investigated the association between infant vitamin D supplementation and later pre-eclampsia, a disorder suggested to be dominated by Th1 response. We used data on 2969 women born in the Northern Finland Birth Cohort 1966 of whom 68 (2.3%) had pre-eclampsia in their first pregnancy. Risk of pre-eclampsia was halved (OR 0.49, 95% confidence interval (CI) 0.26-0.92) in participants who had received vitamin D supplementation regularly during the first year of life and this association was not affected by adjustment for own birth order, birth weight, gestational age, social class in 1966 and hospitalizations or pregnancy-induced hypertension of their mothers. Together with earlier observations on a reduced risk of type 1 diabetes after vitamin D supplementation, these data suggest that vitamin D intake in infancy may affect long-term programming of the immune response pattern.
Asunto(s)
Fenómenos Fisiológicos Nutricionales del Lactante , Preeclampsia/epidemiología , Preeclampsia/inmunología , Células TH1 , Células Th2 , Vitamina D/administración & dosificación , Adulto , Estudios de Cohortes , Suplementos Dietéticos , Femenino , Finlandia/epidemiología , Estudios de Seguimiento , Humanos , Lactante , Recién Nacido , Oportunidad Relativa , Embarazo , Prevalencia , Estudios Prospectivos , Factores de Riesgo , Vitaminas/administración & dosificaciónRESUMEN
PROBLEM: To elucidate the efficacy of the treatment using a Japanese-modified Chinese herbal medicine, Sairei-to, and low-dose aspirin with or without a corticosteroid hormone for the patients with adverse pregnancy histories positive for anti-phospholipid antibodies. METHOD OF STUDY: Fifteen cases positive for anti-phospholipid antibodies, who had experienced preterm delivery in which an extremely low birthweight infant (<1000 g) was born as a result of intrauterine growth restriction with or without severe preeclampsia, were treated with the medication according to the current protocol. Four cases with the same condition, who were treated with only low-dose aspirin, or without medication, were chosen as a control population. The pregnancy outcome was compared between the two groups. RESULTS: The rate of patients in whom the next pregnancy continued until the 36th week of gestation or later was significantly higher in treated patients (80.0%) compared with the control population (0%). CONCLUSIONS: In this series, we obtained case report data that Sairei-to may provide some benefit for patients with reproductive disorders positive for anti-phospholipid antibodies; however, randomized controlled trial evidence is needed before current treatment can be recommended.
Asunto(s)
Síndrome Antifosfolípido/inmunología , Aspirina/farmacología , Medicamentos Herbarios Chinos/farmacología , Retardo del Crecimiento Fetal/prevención & control , Preeclampsia/prevención & control , Prednisolona/farmacología , Adulto , Antiinflamatorios no Esteroideos/farmacología , Síndrome Antifosfolípido/complicaciones , Femenino , Retardo del Crecimiento Fetal/inmunología , Humanos , Preeclampsia/inmunología , EmbarazoRESUMEN
Preeclampsia is a multisystem disorder manifest by hypertension after 20 weeks' gestation associated with end organ damage, usually proteinuria. The placenta is thought to be pivotal in the pathogenesis of the disease. Both the placenta and the maternal systemic response are characterised by heightened inflammation. Garlic has been shown to have anti-inflammatory and pro-apoptotic properties amongst others. It was hypothesised that treating placental explants with garlic may inhibit the production of inflammatory cytokines (interleukin-6 (IL-6) and tumour necrosis factor (TNFalpha)) and stimulate the production of anti-inflammatory cytokines (interleukin-10 (IL-10)) by the placental explants. Garlic, we hypothesised, would also stimulate apoptosis in the explants as measured by soluble TNF-related apoptosis-inducing ligand/Apo-2L (sTRAIL) production. Normal placental explants (n=5) and explants from women who had preeclampsia (n=4) were cultured in the presence of various garlic concentrations (10-1000 microg/mL). The lowest garlic concentration (10 microg/mL) increased the normal explant production of IL-10 by 29.2% (12.2, 57.5%; p<0.01) while inhibiting the production of IL-6 by 23.5% (8.9, 32.5%; p<0.01) (normal explants) and TNFalpha by 19.4% (4.5, 35.3%; p<0.05) (preeclamptic explants). Garlic resulted in an increase in IL-10 production at lower doses (normal explants only) and inhibition of the production of IL-10 at higher doses (normal and preeclamptic explants). Garlic also resulted in a dose-dependent reduction of IL-6 and TNFalpha. Initially there was no change in sTRAIL production; however, at the highest garlic concentrations there was a significant increase in production. We thus conclude that garlic may have an immunomodulatory effect on normal and preeclamptic placentas.
Asunto(s)
Ajo , Interleucina-10/biosíntesis , Interleucina-6/antagonistas & inhibidores , Placenta/inmunología , Preeclampsia/inmunología , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Adulto , Proteínas Reguladoras de la Apoptosis/biosíntesis , Proteínas Reguladoras de la Apoptosis/inmunología , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Concentración de Iones de Hidrógeno , Técnicas In Vitro , Interleucina-6/biosíntesis , Glicoproteínas de Membrana/biosíntesis , Glicoproteínas de Membrana/inmunología , Placenta/efectos de los fármacos , Extractos Vegetales/farmacología , Preeclampsia/tratamiento farmacológico , Embarazo , Ligando Inductor de Apoptosis Relacionado con TNF , Factor de Necrosis Tumoral alfa/biosíntesis , Factor de Necrosis Tumoral alfa/inmunologíaRESUMEN
OBJECTIVES: Recent evidence suggests a role of an excessive maternal inflammatory response in the pathogenesis of preeclampsia. Whether this imbalance can be transferred from mother to breast milk remains to be established. DESIGN AND METHODS: 15 preeclamptic and 15 healthy pregnant women were recruited in this study. Colostrum and milk samples were collected postpartum in the first 48 h and at 30 days, respectively. Samples were analyzed for interleukin (IL)-1beta, IL-6, IL-8, tumor necrosis factor (TNF)-alpha and soluble IL-2R (sIL-2R) levels with chemiluminescence enzyme immunometric assays. RESULTS: Colostrum cytokine levels corrected for gestational age and type of delivery were not significantly different in the two groups. Cytokine levels significantly decreased in mature milk versus colostrum in the control group (P < 0.05), but did not significantly decrease in the preeclampsia group (P > 0.05), except for TNF-alpha (P < 0.05). Mature milk IL-8 and TNF-alpha levels were higher in the preeclampsia group versus controls (P < 0.05). CONCLUSION: Results of this study show that proinflammatory cytokines in breast milk exhibit biological variation at different periods of human lactation. In preeclampsia, high cytokine levels persist at least for 30 days. These results suggest that preeclampsia may affect milk cytokine balance and offer an immunological signal for the host defense in high-risk neonates.
Asunto(s)
Calostro/inmunología , Citocinas/metabolismo , Leche Humana/inmunología , Preeclampsia/inmunología , Adulto , Femenino , Humanos , Inflamación/fisiopatología , Interleucina-1/análisis , Interleucina-6/análisis , Interleucina-8/análisis , Embarazo , Receptores de Interleucina-2/análisis , Solubilidad , Factor de Necrosis Tumoral alfa/análisisRESUMEN
OBJECTIVE: To study the effect of prepared rhubarb in treating patients with pregnancy induced hypertension (PIH) and its therapeutic mechanisms. METHODS: Prepared rhubarb and nifedipine were given to the study group, while the nifedipine was given to the control group alone. The blood lipid, renal function, blood coagulation, fibrinolysis and immunological parameters were monitored. RESULTS: In the study group, (1) Levels of triglycerides (TG) and low density lipoprotein-cholesterol (LDL-C) decreased and high density lipoprotein-cholesterol (HDL-C) level increased significantly; (2) Plasma level of fibronectin (FN) and plasminogen activator inhibitor (PAI) lowered significantly, plasma antithrombin (AT-III) level unchanged; (3) Serum beta 2 microglobulin (beta 2-MG) level and urinary level of N-acetyl-beta-D-glucosaminidase (NAG) and interleukin-6 (IL-6) decreased significantly; (4) CD8 of blood increased, CD4/CD8 and circulating immune complex (CIC) of blood reduced obviously. All of the above-mentioned parameters in the study group were significantly different from that of the control group. CONCLUSION: The prepared rhubarb could reduce the vascular endothelial cell's damage significantly and alter the immune balance, which is effective in treating the PIH.